Searched for
CHOLESTEROL DRUGS
Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...
US drugs site TrumpRx to list 600 generics as Donald Trump targets lower pricesPresident Donald Trump is expanding access to affordable medicines. The government website TrumpRx.gov will now list over 600 generic drugs...
Weight-loss drug semaglutide set to get cheaper as generic wave builds in IndiaPrices for generic semaglutide, a popular weight-loss drug, are expected to fall by more than half in the coming months. This sharp decline...
The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
Trump unveils deal with Regeneron to lower drug prices as part of most-favored-nation initiativeRegeneron will reduce prices for its drugs on Medicaid. A cholesterol drug, Praluent, will be available for USD 225 on Trump's discounted d...
Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
Are you taking too many medicines? Study says stopping some drugs could be safe for this age groupFrail seniors and those with limited life expectancy may not need all their long-term medications. A global review indicates that carefully...
New daily pill could slash Cholesterol for patients who don’t respond to Statins, study findsA new pill called Enlicitide may help people who don’t get results from statins. The drug showed big drops in bad cholesterol in early test...
Novartis offers payment plan for high-cost heart medicineNovartis introduces a financing scheme with Pine Labs for its cholesterol-lowering drug, Sybrava (inclisiran), in India, aiming to broaden ...
Zydus Lifesciences gets USFDA nod for generic cholesterol lowering drugZydus Lifesciences Ltd. has secured final USFDA approval to manufacture generic Niacin extended-release tablets in 500 mg, 750 mg, and 1,00...
When do you need a cholesterol test? Foods that can improve your numbers. Monitoring and managing cholesterol is crucial for heart health. Understanding when to test and interpret results can be overwhelming. Ex...
Lupin receives USFDA nod for cholesterol drugLupin said it has received 505 (b) (2) NDA approval for its Nikita Pitavastatin tablets 1mg, 2mg and 4mg from the United States Food and Dr...
Alembic Pharma's cholesterol drug gets US FDA nodThe approved product is therapeutically equivalent to the reference listed drug product Trilipix Delayed-Release capsules of Abbvie Inc.
Zydus Cadila gets USFDA nod for anti-cholesterol drugThe company has received final approval from the US Food and Drug Administration (USFDA) to market the product, Zydus Cadila said in a stat...
US Food and Drug Administration approves drug to cut cholesterolMorgan Liscinsky, an FDA spokeswoman, said high levels of LDL cholesterol were a known risk factor for heart disease.
- FDA restricts anti-cholestrol drug heavy dosage
The US drug regulator has put restrictions on use of high dose of anti-cholesterol drug simvastatin with insignificant impact on Indian rev...
- Ranbaxy can advance Lipitor in Australia
In A mixed verdict for Ranbaxy Laboratories in its ongoing battle to launch a generic version of anti-cholesterol drug Lipitor, a full fede...
- Pfizer halts cholesterol drug trial, shares may take a hit
Pfizer’s shares will likely plunge after the world’s biggest drugmaker unexpectedly ended development of its most important new drug, a cho...
- Cholesterol drugmakers brace for competition
The makers of cholesterol drugs are promoting their products ahead of a major change that is expected to trigger more competition in the ma...